A Study to Investigate Lung Deposition of Radiolabelled OligoG

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Cystic Fibrosis
Interventions
DRUG

Radiolabelled OligoG CF-5/20 DPI

Inhalation with dry powder by Mia Monodose Inhaler

DRUG

Radiolabelled OligoG CF-5/20 6% Solution

Inhalation with aerosolised solution by nebuliser

Trial Locations (1)

G4 0SF

Bio-Images Research Ltd, Glasgow

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

AlgiPharma AS

INDUSTRY

lead

BDD Pharma Ltd

INDUSTRY

NCT01991028 - A Study to Investigate Lung Deposition of Radiolabelled OligoG | Biotech Hunter | Biotech Hunter